• Hunkler HJ et al. Non-coding RNAs: key regulators of reprogramming, pluripotency, and cardiac cell specification with therapeutic perspective for heart regeneration. Cardiovasc Res. 2022 Dec 9;118(15):3071-3084.
• Sommer W et al. Heart transplantation across preformed donor-specific antibody barriers using a perioperative desensitization protocol. Am J Transplant. 2022 Aug;22(8):2064-2076.
• Ledwoch N et al. Identification of distinct secretory patterns and their regulatory networks of ischemia versus reperfusion phases in clinical heart transplantation. Cytokine. 2022 Jan;149:155744.
• Rojas SV et al. Ex-Vivo Preservation with the Organ Care System in High Risk Heart Transplantation. Life (Basel). 2022 Feb 7;12(2):247.

• Reig M et al. BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update.J Hepatol. 2022 Mar;76(3):681-693.
• Montano-Loza AJ et al. Risk factors and outcomes associated with recurrent autoimmune hepatitis following liver transplantation. J Hepatol. 2022 Jul;77(1):84-97.
• Laue T et al. Hepatitis A Immunity and Paediatric Liver Transplantation-A Single-Centre Analysis. Children (Basel). 2022 Dec 12;9(12):1953.
• Junge N et al. Intra-Abdominal Hypertension and Compartment Syndrome after Pediatric Liver Transplantation: Incidence, Risk Factors and Outcome. Children (Basel). 2022 Dec 18;9(12):1993.
• Baumann U et al. Prognosis of Children Undergoing Liver Transplantation: A 30-Year European Study. Pediatrics. 2022 Oct 1;150(4):e2022057424.
• Schulte B et al. Metamizole-Associated Risks in Decompensated Hepatic Cirrhosis. Dtsch Arztebl Int. 2022 Oct 14;119(41):687-693.
• Honerkamp I et al. Surgical Procedures in Patients Awaiting Liver Transplantation: Complications and Impact on the Liver Function. J Clin Exp Hepatol. 2022 Jan-Feb;12(1):68-79.
• de Ville de Goyet J. et al. Variability of Care and Access to Transplantation for Children with Biliary Atresia Who Need a Liver Replacement. J Clin Med. 2022 Apr 12;11(8):2142.
• Laue T et al. Long-Term Varicella Zoster Virus Immunity in Paediatric Liver Transplant Patients Can Be Achieved by Booster Vaccinations-A Single-Centre, Retrospective, Observational Analysis. Children (Basel). 2022 Jan 19;9(2):130.
• Madadi-Sanjani O et al. Centralization of Biliary Atresia: Has Germany Learned Its Lessons? Eur J Pediatr Surg. 2022 Jun;32(3):233-239.
• Stasch L et al. Parental Disease Specific Knowledge and Its Impact on Health-Related Quality of Life. Children (Basel). 2022 Jan 11;9(1):98.
• Beetz O et al. Porcine Liver Transplantation Without Veno-venous Bypass As an Extended Criteria Donor Model. J Vis Exp. 2022 Aug 17;(186).
• Saunders EA et al. Outcome and safety of a surveillance biopsy guided personalized immunosuppression program after liver transplantation. Am J Transplant. 2022 Feb;22(2):519-531.
• Bukova M et al. Long-term outcome of primary percutaneous stent angioplasty for pediatric posttransplantation portal vein stenosis. Liver Transpl. 2022 Sep;28(9):1463-1474.
• de Ville de Goyet Jet al. European Liver Transplant Registry: Donor and transplant surgery aspects of 16,641 liver transplantations in children. Hepatology. 2022 Mar;75(3):634-645.
• Memaran N et al. Telomere length is associated with intima-media thickness in pediatric liver transplant patients: A prospective cohort study. Liver Transpl. 2022 Nov;28(11):1766-1775.
• Baumann AK et al. Elevated fractional donor-derived cell-free DNA during subclinical graft injury after liver transplantation. Liver Transpl. 2022 Dec;28(12):1911-1919.
• Beetz O et al. Interleukin-18 and High-Mobility-Group-Protein B1 are Early and Sensitive Indicators for Cell Damage During Normothermic Machine Perfusion after Prolonged Cold Ischemic Storage of Porcine Liver Grafts. Transpl Int. 2022 Oct 20;35:10712.
• Chruscinski A et al. Evaluation of a gene expression biomarker to identify operationally tolerant liver transplant recipients: the LITMUS trial. Clin Exp Immunol. 2022 Jan 28;207(1):123-139.
• Junge N et al. Cold Ischemia Time and Graft Fibrosis Are Associated with Autoantibodies after Pediatric Liver Transplantation: A Retrospective Cohort Study of the European Reference Network TransplantChild. Children (Basel). 2022 Feb 17;9(2):275.
• Greite R et al. Different Acute Kidney Injury Patterns after Renal Ischemia Reperfusion Injury and Extracorporeal Membrane Oxygenation in Mice. Int J Mol Sci. 2022 Sep 20;23(19):11000.
• Ohlendorf J et al. Ileal Bile Acid Transporter Inhibition Reduces Post-Transplant Diarrhea and Growth Failure in FIC1 Disease-A Case Report.  Children (Basel). 2022 May 5;9(5):669.
• Kirchner T et al. Reduced humoral but stable cellular SARS-CoV-2-specific immunity in liver transplant recipients in the first year after COVID-19. PLoS One. 2022 Nov 2;17(11):e0276929.
• Kettler B et al. Liver Transplantation After Organ Donation Due to Hydrogen Sulfide Intoxication: Report of the First Case. Transplantation. 2022 Apr 1;106(4):e247-e248.
• Oldhafer F et al. Hypothermic Oxygenated Perfusion for Transplantation of a Pediatric Extended Right Lobe: Report of the First Case. Transplantation. 2022 Jun 1;106(6):e322-e323.

• Glanville AR et al. Bronchiolitis obliterans syndrome after lung or haematopoietic stem cell transplantation: current management and future directions. ERJ Open Res. 2022 Jul 25;8(3):00185-2022.
• de Zwart A et al. Respiratory Syncytial Virus, Human Metapneumovirus, and Parainfluenza Virus Infections in Lung Transplant Recipients: A Systematic Review of Outcomes and Treatment Strategies. Clin Infect Dis. 2022 Jul 6;74(12):2252-2260.
• Iablonskii P et al. Indications and outcome after lung transplantation in children under 12 years of age: A 16-year single center experience. J Heart Lung Transplant. 2022 Feb;41(2):226-236.
• Gottlieb J. et al. Lung transplantation for acute respiratory distress syndrome: a retrospective European cohort study. Eur Respir J. 2022 Jun 30;59(6):2102078.
• Rivière A et al. Lung transplantation for interstitial lung disease in idiopathic inflammatory myositis: A cohort study. Am J Transplant. 2022 Dec;22(12):2990-3001.
• Memaran N et al. Cardiovascular Burden Is High in Pediatric Lung Transplant Recipients. Transplantation. 2022 Jul 1;106(7):1465-1472
• Loor et al. Effect of mode of intraoperative support on primary graft dysfunction after lung transplant. J Thorac Cardiovasc Surg. 2022 Nov;164(5):1351-1361.e4.
• Greite R et al. Cell-Free Hemoglobin in Acute Kidney Injury after Lung Transplantation and Experimental Renal Ischemia/Reperfusion. Int J Mol Sci. 2022 Oct 31;23(21):13272.
• Schütz K et al. COVID-19 in pediatric lung transplant recipients: Clinical course and outcome. J Heart Lung Transplant. 2022 Dec 5:S1053-2498(22)02222-7.
• Schlör S et al. Membranes (Basel). 2022 Jul 3;12(7):687. Towards Biohybrid Lung Development: Establishment of a Porcine In Vitro Model.
• Franz M et al. Lung transplant and severe coronary artery disease: results from a single-centre experience. Eur J Cardiothorac Surg. 2022 Jul 11;62(2):ezac348.
• Kneidinger N et a l. Outcome of lung transplant recipients infected with SARS-CoV-2/Omicron/B.1.1.529: a Nationwide German study. Infection. 2022 Sep 9:1-9.
• Olsson KM et al. Refined risk stratification in pulmonary arterial hypertension and timing of lung transplantation. Eur Respir J. 2022 Aug 4;60(2):2103087.
• Doricic J et al. Kidney injury after lung transplantation: Long-term mortality predicted by post-operative day-7 serum creatinine and few clinical factors. PLoS One. 2022 Mar 4;17(3):e0265002.
• Hansmann G et al. Full recovery of right ventricular systolic function in children undergoing bilateral lung transplantation for severe PAH. J Heart Lung Transplant. 2022 Feb;41(2):187-198.
• Gottlieb J et al. Benefit of monoclonal antibodies in early treatment of COVID-19 after lung transplantation: a retrospective analysis in two centres. Eur Respir J. 2022 Jul 21;60(1):2200124.
• Seeliger B et al. Graphic narrative based informed consent for bronchoscopy improves satisfaction in patients after lung-transplantation: A randomized controlled trial. Patient Educ Couns. 2022 Apr;105(4):949-955.
• Schwarz S et al. Gamma-glutamyltransferase is a strong predictor of secondary sclerosing cholangitis after lung transplantation for COVID-19 ARDS. J Heart Lung Transplant. 2022 Oct;41(10):1501-1510.
• Kayser MZ et al. Clinical decision making is improved by BioFire Pneumonia Plus in suspected lower respiratory tract infection after lung transplantation: Results of the prospective DBATE-IT study. Transpl Infect Dis. 2022 Feb;24(1):e13725.
• Kneidinger N et al. Five-year Outcome of an Early Everolimus-based Quadruple Immunosuppression in Lung Transplant Recipients: Follow-up of the 4EVERLUNG Study. Transplantation. 2022 Sep 1;106(9):1867-1874.

• Liao CM et al. Induction of ferroptosis selectively eliminates senescent tubular cells. Am J Transplant. 2022 Sep;22(9):2158-2168.
• Jagodzinski C et al. Growth hormone treatment in the pre-transplant period is associated with superior outcome after pediatric kidney transplantation. Pediatr Nephrol. 2022 Apr;37(4):859-869.
• Teng L et al. SLAMF8 Participates in Acute Renal Transplant Rejection via TLR4 Pathway on Pro-Inflammatory Macrophages. Front Immunol. 2022 Apr 1;13:846695.
• Schwarz A et al. Graft function and pregnancy outcomes after kidney transplantation. BMC Nephrol. 2022 Jan 12;23(1):27.
• Stabouli S et al. Assessment and management of obesity and metabolic syndrome in children with CKD stages 2-5 on dialysis and after kidney transplantation-clinical practice recommendations from the Pediatric Renal Nutrition Taskforce. Pediatr Nephrol. 2022 Jan;37(1):1-20.
• Meyer N et al. Fetal endothelial colony-forming cell impairment after maternal kidney transplantation. Pediatr Res. 2022 Jun 22.
• Mikuteit M et al. Assessment of cognitive functioning after living kidney donation: A cross-sectional pilot study. PLoS One. 2022 Feb 25;17(2):e0264284.
• Yin D et al. A Modified Surgical Technique for Kidney Transplantation in Mice. J Vis Exp. 2022 Jul 22;(185).
• Taylan C et al. Safety of Therapeutic Apheresis in Children and Adolescents. Front Pediatr. 2022 Apr 12;10:850819.
• Sugianto RI et al. Findings from 4C-T Study demonstrate an increased cardiovascular burden in girls with end stage kidney disease and kidney transplantation. Kidney Int. 2022 Mar;101(3):585-596.
• Maassen H et al. Nitric oxide and long-term outcomes after kidney transplantation: Results of the TransplantLines cohort study. Nitric Oxide. 2022 Aug 1;125-126:1-11.
• Halloran PF et al. Archetypal Analysis of Injury in Kidney Transplant Biopsies Identifies Two Classes of Early AKI. Front Med (Lausanne). 2022 Apr 7;9:817324.
• Boehm M et al. Kidney Transplantation in Small Children: Association Between Body Weight and Outcome-A Report From the ESPN/ERA-EDTA Registry. Transplantation. 2022 Mar 1;106(3):607-614.
• Vinson AJ et al. Age-dependent Sex Differences in Graft Loss After Kidney Transplantation. Transplantation. 2022 Jul 1;106(7):1473-1484.
• Labriffe M et al. Machine learning-supported interpretation of kidney graft elementary lesions in combination with clinical data. Am J Transplant. 2022 Dec;22(12):2821-2833.
• Birkefeld K et al. Prevalence of Mental Disorders in a German Kidney Transplant Population: Results of a KTx360°-Substudy. J Clin Psychol Med Settings. 2022 Dec;29(4):963-976.
• Hoff U et al. The mTOR inhibitor Rapamycin protects from premature cellular senescence early after experimental kidney transplantation.PLoS One. 2022 Apr 21;17(4):e0266319.
• Halloran PF et al. Molecular diagnosis of ABMR with or without donor-specific antibody in kidney transplant biopsies: Differences in timing and intensity but similar mechanisms and outcomes. Am J Transplant. 2022 Aug;22(8):1976-1991.
• Van Loon E et al. Biological pathways and comparison with biopsy signals and cellular origin of peripheral blood transcriptomic profiles during kidney allograft pathology. Kidney Int. 2022 Jul;102(1):183-195.
• Seiler LK et al. An Antibody-Aptamer-Hybrid Lateral Flow Assay for Detection of CXCL9 in Antibody-Mediated Rejection after Kidney Transplantation. Diagnostics (Basel). 2022 Jan 25;12(2):308.
• Ghandili S et al. Donor-transmitted extramedullary acute myeloid leukaemia after living donor kidney transplantation. Br J Haematol. 2022 Jul;198(1):199-202.
• Prytula A et al. Hyperparathyroidism Is an Independent Risk Factor for Allograft Dysfunction in Pediatric Kidney Transplantation. Kidney Int Rep. 2022 Oct 28;8(1):81-90.

• Vogel A et al. Hepatocellular carcinoma. Lancet. 2022 Oct 15;400(10360):1345-1362.
• Manns MP, Maasoumy B. Breakthroughs in hepatitis C research: from discovery to cure. Nat Rev Gastroenterol Hepatol. 2022 Aug;19(8):533-550.
• Pfister ED et al. Extrahepatic manifestations of progressive familial intrahepatic cholestasis syndromes: Presentation of a case series and literature review. Liver Int. 2022 May;42(5):1084-1096.
• Joean O et al. Chest Infections After Lung Transplantation. Chest. 2022 Apr;161(4):937-948.
• Roesel MJ et al. The role of ex-situ perfusion for thoracic organs. Curr Opin Organ Transplant. 2022 Oct 1;27(5):466-473
• Starke H et al. Intraoperative Circulatory Support in Lung Transplantation: Current Trend and Its Evidence. Life (Basel). 2022 Jul 7;12(7):1005.
• Mannon RB et al. A multi-faceted approach to sex and gender equity in solid organ transplantation: The Women in Transplantation Initiative of The Transplantation Society. Front Immunol. 2022 Sep 26;13:1006855.
• Bartling T et al. How Should Deceased Donor Organs Be Allocated? The Patient's Perspective Derived from Semi-Structured Interviews. Patient Prefer Adherence. 2022 Aug 30;16:2375-2385.
• Franke D. The diagnostic value of Doppler ultrasonography after pediatric kidney transplantation. Pediatr Nephrol. 2022 Jul;37(7):1511-1522.
• Siegl J et al. Split-Combine Click-SELEX Reveals Ligands Recognizing the Transplant Rejection Biomarker CXCL9. ACS Chem Biol. 2022 Jan 21;17(1):129-137.
• Halloran PF et al. The Biology and Molecular Basis of Organ Transplant Rejection. Handb Exp Pharmacol. 2022;272:1-26.
• Valdivia E et al. Genetic Modification of Limbs Using Ex Vivo Machine Perfusion. Hum Gene Ther. 2022 Apr;33(7-8):460-471.
• Mund E et al. Clinically latent and autopsy-verified inflammatory disorders and malignant tumours in transplant patients. J Clin Pathol. 2022 Feb;75(2):112-116.
• Schulze Lammers FC et al. Antiviral T-Cell Frequencies in a Healthy Population: Reference Values for Evaluating Antiviral Immune Cell Profiles in Immunocompromised Patients. J Clin Immunol. 2022 Apr;42(3):546-558.
• Wilkinson JD et al. The IPTA Nashville consensus conference on post-transplant lymphoproliferative disorders after solid organ transplantation in children: I-Methodology for the development of consensus practice guidelines. Pediatr Transplant. 2022 Nov 11:e14333.
• Kremer J et al. Membrane-bound IL-2 improves the expansion, survival, and phenotype of CAR Tregs and confers resistance to calcineurin inhibitors. Front Immunol. 2022 Dec 23;13:1005582.
• Dastagir K et al. A New Standardized Clinical Model for Evaluation of Nerve Guides: A Single-Blinded Randomized Controlled Prospective Study. Plast Reconstr Surg. 2022 Dec 1;150(6):1298-1306.
• Grossi PA et al. Cytomegalovirus Management in Solid Organ Transplant Recipients: A Pre-COVID-19 Survey From the Working Group of the European Society for Organ Transplantation. Transpl Int. 2022 Jun 22;35:10332.

• Drakhlis L et al. Human heart-forming organoids recapitulate early heart and foregut development. Nat Biotechnol. 2021 Jun;39(6):737-746.
• Ius F et al. Cardiac valve operations after solid organ transplantation: A single-center experience. J Thorac Cardiovasc Surg. 2021 Feb;161(2):595-606.e4.
• Mariani S et al. Sex differences in outcomes following less-invasive left ventricular assist device implantation. Ann Cardiothorac Surg. 2021 Mar;10(2):255-267
• Avsar M et al. Pediatric urgent heart transplantation with age or weight mismatched donors: Reducing waiting time by enlarging donor criteria. J Card Surg. 2021 Dec;36(12):4551-4557.
• Heusser K et al. Sympathetic vasoconstrictor activity before and after left ventricular assist device implantation in patients with end-stage heart failure. Eur J Heart Fail. 2021 Nov;23(11):1955-1959.
• Natanov R et al. Minimal invasive temporary percutaneous right ventricular circulatory support after left ventricular assist device implantation. Interact Cardiovasc Thorac Surg. 2021 Oct 29;33(5):795-800.

• Yang T et al. Therapeutic HNF4A mRNA attenuates liver fibrosis in a preclinical model. J Hepatol. 2021 Dec;75(6):1420-1433.
• Cornberg M et al. EASL position paper on the use of COVID-19 vaccines in patients with chronic liver diseases, hepatobiliary cancer and liver transplant recipients. J Hepatol. 2021 Apr;74(4):944-951.
• Vionnet J et al. Non-invasive alloimmune risk stratification of long-term liver transplant recipients. J Hepatol. 2021 Dec;75(6):1409-1419.
• Kaluza AJ et al. A Sorrow Shared Is a Sorrow Halved? Patient and Parental Anxiety Associated with Venipuncture in Children before and after Liver Transplantation. Children (Basel). 2021 Aug 11;8(8):691.
• Goldschmidt I et al. Identification of Impaired Executive Functioning after Pediatric Liver Transplantation Using Two Short and Easily Applicable Tests: Cognitive Functioning Module PedsQL and Children's Color Trail Test. Children (Basel). 2021 Jul 2;8(7):571.
• Mederacke YS et al. T cell receptor repertoires within liver allografts are different to those in the peripheral blood. J Hepatol. 2021 May;74(5):1167-1175.
• Brüggenwirth IMA et al. The Liver Retransplantation Risk Score: a prognostic model for survival after adult liver retransplantation. Transpl Int. 2021 Oct;34(10):1928-1937.
• Leiskau C et al. Recipient-Specific Risk Factors Impairing Patient and Graft Outcome after Pediatric Liver Transplantation-Analysis of 858 Transplantations in 38 Years. Children (Basel). 2021 Jul 27;8(8):641.
• Berenguer M et al. Characteristics, Trends, and Outcomes of Liver Transplantation for Primary Sclerosing Cholangitis in Female Versus Male Patients: An Analysis From the European Liver Transplant Registry. Transplantation. 2021 Oct 1;105(10):2255-2262.
• Markiewicz-Kijewska M et al. ABO Incompatible Liver Transplantation in Children: A 20 Year Experience from Centres in the TransplantChild European Reference Network. Children (Basel). 2021 Aug 31;8(9):760.
• Leiskau C et al. Low-dose steroids do make a difference: Independent risk factors for impaired linear growth after pediatric liver transplantation. Pediatr Transplant. 2021 Jun;25(4):e13989.
• Modin L et al. A Case Series on Genotype and Outcome of Liver Transplantation in Children with Niemann-Pick Disease Type C. Children (Basel). 2021 Sep 17;8(9):819.
• Waldron LS et al. Diaphragmatic Hernia following Pediatric Liver Transplantation: An Underappreciated Complication Prone to Recur. Eur J Pediatr Surg. 2021 Oct;31(5):396-406.
• Memaran N et al. Prospective assessment of subclinical cardiovascular damage and associated factors in liver transplant recipients. Transpl Int. 2021 Jan;34(1):127-138.
• Aregay A et al. Distinct Immune Imprints of Post-Liver Transplantation Hepatitis C Persist Despite Viral Clearance. Liver Transpl. 2021 Jun;27(6):887-899.
• Laue T et al. Under-Vaccination in Pediatric Liver Transplant Candidates with Acute and Chronic Liver Disease-A Retrospective Observational Study of the European Reference Network TransplantChild. Children (Basel). 2021 Aug 3;8(8):675.
• Oldhafer F et al. Supportive Hepatocyte Transplantation after Partial Hepatectomy Enhances Liver Regeneration in a Preclinical Pig Model. Eur Surg Res. 2021;62(4):238-247.
• Cornberg M, Eberhardt CS. Protected or not protected, that is the question - First data on COVID-19 vaccine responses in patients with NAFLD and liver transplant recipients. J Hepatol. 2021 Aug;75(2):265-266.
• Flemming G et al. Survival Benefits Following Liver Transplantation: A Matched-pair Analysis in Pediatric Patients With Cystic Fibrosis. J Pediatr Gastroenterol Nutr. 2021 Sep 1;73(3):385-390.
• Visseren T et al. Recurrence of primary sclerosing cholangitis after liver transplantation - analysing the European Liver Transplant Registry and beyond. Transpl Int. 2021 Aug;34(8):1455-1467.
• Ohlendorf J et al. Two Sides of a Coin: Parental Disease-Specific Training as Seen by Health Care Practitioners and Parents in Pediatric Liver Transplantation. Children (Basel). 2021 Sep 21;8(9):827.
• Feldbrügge L et al. Health-Related Quality of Life and Mental Health after Surgical Treatment of Hepatocellular Carcinoma in the Era of Minimal-Invasive Surgery: Resection versus Transplantation. Healthcare (Basel). 2021 Jun 9;9(6):694.
• Friman S et al. Long-term, Prolonged-release Tacrolimus-based Immunosuppression in De Novo Liver Transplant Recipients: 5-year Prospective Follow-up of Patients in the DIAMOND Study. Transplant Direct. 2021 Jul 9;7(8):e722.
• Götz JK et al. Current Evidence on the Clinical Relevance of Donor-specific Antibodies in Paediatric Liver Transplantation. J Pediatr Gastroenterol Nutr. 2021 Jun 1;72(6):788-793.
• Kuebler JF et al. Adjuvant Therapy with Budesonide Post-Kasai Reduces the Need for Liver Transplantation in Biliary Atresia. J Clin Med. 2021 Dec 9;10(24):5758.

• Braubach P et al. Pulmonary Fibroelastotic Remodelling Revisited. Cells. 2021 Jun 1;10(6):1362.
• Le Pavec J et al. Lung transplantation for sarcoidosis: outcome and prognostic factors. Eur Respir J. 2021 Aug 5;58(2):2003358.
• Girgis RE, Hoeper MM. Pulmonary hypertension in fibrosing idiopathic interstitial pneumonia: Uncertainties, challenges and opportunities. J Heart Lung Transplant. 2021 Sep;40(9):872-881.
• Joean O et al. Characteristics and clinical implications of pleural effusions after lung transplantation: A retrospective analysis of 195 thoracocenteses in 113 patients. Clin Transplant. 2021 May;35(5):e14267.
• Nakagiri T et al. α1-Antitrypsin attenuates acute rejection of orthotopic murine lung allografts. Respir Res. 2021 Nov 17;22(1):295.
• Kamp JC et al. COVID-19 in lung transplant recipients-Risk prediction and outcomes. PLoS One. 2021 Oct 6;16(10):e0257807.
• Iske J et al. The potential of ex vivo lung perfusion on improving organ quality and ameliorating ischemia reperfusion injury. Am J Transplant. 2021 Dec;21(12):3831-3839.
• Hitz AM et al. Donor NK and T Cells in the Periphery of Lung Transplant Recipients Contain High Frequencies of Killer Cell Immunoglobulin-Like Receptor-Positive Subsets. Front Immunol. 2021 Dec 13;12:778885.
• Nöhre M et a. The Transplant Evaluation Rating Scale Predicts Clinical Outcomes 1 Year After Lung Transplantation: A Prospective Longitudinal Study. Front Psychiatry. 2021 Aug 26;12:704319.
• Pflaum M et al. Towards Biohybrid Lung: Induced Pluripotent Stem Cell Derived Endothelial Cells as Clinically Relevant Cell Source for Biologization. Micromachines (Basel). 2021 Aug 19;12(8):981
• Gräff P et al. Lung Transplantation following Emergency Pneumonectomy in a Polytraumatized 18-Year-Old. Case Rep Transplant. 2021 Dec 29;2021:5584827.
• Salman J et al. Intraoperative Extracorporeal Circulatory Support in Lung Transplantation for Pulmonary Fibrosis. Ann Thorac Surg. 2021 Apr;111(4):1316-1324.
• Gottlieb J et al. Disease progression in patients with the restrictive and mixed phenotype of Chronic Lung Allograft dysfunction-A retrospective analysis in five European centers to assess the feasibility of a therapeutic trial. PLoS One. 2021 Dec 23;16(12):e0260881.
• Gottlieb J et al. Viral load-guided immunosuppression after lung transplantation (VIGILung)-study protocol for a randomized controlled trial. Trials. 2021 Jan 11;22(1):48.
• Aburahma K et al. Liver-first strategy for a combined lung and liver transplant in patients with cystic fibrosis. Eur J Cardiothorac Surg. 2021 Oct 22;60(4):822-830.
• Hacker KS et al. Delayed non-myeloablative irradiation to induce long-term allograft acceptance in a large animal lung transplantation model. Transpl Immunol. 2021 Apr;65:101350.
• Draeger H et al. Impact of unilateral diaphragm elevation on postoperative outcomes in bilateral lung transplantation - a retrospective single-center study. Transpl Int. 2021 Mar;34(3):474-487.

• Haffner D, Leifheit-Nestler M. CKD-MBD post kidney transplantation. Pediatr Nephrol. 2021 Jan;36(1):41-50.
• Budde K et al. Conversion from Calcineurin Inhibitor- to Belatacept-Based Maintenance Immunosuppression in Renal Transplant Recipients: A Randomized Phase 3b Trial. J Am Soc Nephrol. 2021 Dec 1;32(12):3252-3264.
• Grohs J et al. Determinants of growth after kidney transplantation in prepubertal children. Pediatr Nephrol. 2021 Jul;36(7):1871-1880.
• Müller A, Meier M. Assessment of Renal Volume with MRI: Experimental Protocol. Methods Mol Biol. 2021;2216:369-382.
• Vinson AJ et al. Sex matters: COVID-19 in kidney transplantation. Kidney Int. 2021 Mar;99(3):555-558.
• Schwarz A et al. Risk Factors Influencing the Outcomes of Kidney Re-Transplantation. Ann Transplant. 2021 Jul 16;26:e928922.
• Hennemann K et al. Organ integration in kidney transplant patients - Results of a KTx360° substudy. J Psychosom Res. 2021 Jun;145:110464.
• Schmidbauer M et al. Diffusion-Weighted Imaging and Mapping of T1 and T2 Relaxation Time for Evaluation of Chronic Renal Allograft Rejection in a Translational Mouse Model. J Clin Med. 2021 Sep 23;10(19):4318.
• Feddersen N et al. Adherence in pediatric renal recipients and its effect on graft outcome, a single-center, retrospective study. Pediatr Transplant. 2021 May;25(3):e13922.
• Beetz O et al. Simultaneous heart-kidney transplantation results in respectable long-term outcome but a high rate of early kidney graft loss in high-risk recipients - a European single center analysis. BMC Nephrol. 2021 Jul 9;22(1):258.
• Post A et al. Whole-body arginine dimethylation is associated with all-cause mortality in adult renal transplant recipients. Amino Acids. 2021 Apr;53(4):541-554.
• Beetz O et al. Surgical complications in pediatric kidney transplantation-Incidence, risk factors, and effects on graft survival: A retrospective single-center study. Pediatr Transplant. 2021 Mar;25(2):e13871.
• Kraemer TD et al. Changes in AZGP1 Serum Levels and Correlation With Pulse Wave Velocity After Kidney Transplantation. Front Cardiovasc Med. 2021 Jul 5;8:692213.
• Einecke G et al. Factors associated with kidney graft survival in pure antibody-mediated rejection at the time of indication biopsy: Importance of parenchymal injury but not disease activity. Am J Transplant. 2021 Apr;21(4):1391-1401.
• Krause AV et al. Use of an electronic medication monitoring device to estimate medication adherence in kidney transplant patients. Transl Behav Med. 2021 Apr 7;11(3):842-851.
• Stocklassa T et al. Sex Differences in Subclinical Cardiovascular Organ Damage After Renal Transplantation: A Single-Center Cohort Study. J Womens Health (Larchmt). 2021 Sep;30(9):1352-1361.
• Tinel C et al. Integrative Omics Analysis Unravels Microvascular Inflammation-Related Pathways in Kidney Allograft Biopsies. Front Immunol. 2021 Nov 2;12:738795.
• Baskal S et al. Urinary excretion of amino acids and their advanced glycation end-products (AGEs) in adult kidney transplant recipients with emphasis on lysine: furosine excretion is associated with cardiovascular and all-cause mortality. Amino Acids. 2021 Nov;53(11):1679-1693.
• Hermsen M et al. Quantitative assessment of inflammatory infiltrates in kidney transplant biopsies using multiplex tyramide signal amplification and deep learning. Lab Invest. 2021 Aug;101(8):970-982.
• Zierhut H et al. Course of renal allograft function after diagnosis and treatment of post-transplant lymphoproliferative disorders in pediatric kidney transplant recipients. Pediatr Transplant. 2021 Sep;25(6):e14042.
• Hermsen M et al. Quantitative assessment of inflammatory infiltrates in kidney transplant biopsies using multiplex tyramide signal amplification and deep learning. Lab Invest. 2021 Aug;101(8):970-982.
• Madill-Thomsen KS et al. Donor-Specific Antibody Is Associated with Increased Expression of Rejection Transcripts in Renal Transplant Biopsies Classified as No Rejection. J Am Soc Nephrol. 2021 Nov;32(11):2743-2758.
• Dirks M et al. Reduced microglia activity in patients with long-term immunosuppressive therapy after liver transplantation. Eur J Nucl Med Mol Imaging. 2021 Dec;49(1):234-245.
• Hauser IA et al. Effect of everolimus-based drug regimens on CMV-specific T-cell functionality after renal transplantation: 12-month ATHENA subcohort-study results. Eur J Immunol. 2021 Apr;51(4):943-955.
• Tönshoff B et al. Three-year outcomes from the CRADLE study in de novo pediatric kidney transplant recipients receiving everolimus with reduced tacrolimus and early steroid withdrawal.  Am J Transplant. 2021 Jan;21(1):123-137

• Carvalho-Oliveira M et al. Immunogenetics of xenotransplantation. Int J Immunogenet. 2021 Apr;48(2):120-134.
• Ahlenstiel-Grunow T, Pape L. Virus-specific T cells in pediatric renal transplantation. Pediatr Nephrol. 2021 Apr;36(4):789-796.
• Pilat N et al. T- and B-cell therapy in solid organ transplantation: current evidence and future expectations. Transpl Int. 2021 Sep;34(9):1594-1606.
• Franke D et al. Contrast-enhanced ultrasound of transplant organs - liver and kidney - in children. Pediatr Radiol. 2021 Nov;51(12):2284-2302.
• Janosz E et al. Pulmonary transplantation of alpha-1 antitrypsin (AAT)-transgenic macrophages provides a source of functional human AAT in vivo. Gene Ther. 2021 Sep;28(9):477-493.
• Neubert L et al. Couples After Renal Transplantation: Impact of Sex and Relationship Quality on Adherence in a Prospective Study. Transplant Proc. 2021 Jun;53(5):1599-1605.
• Meyer N et al. Cyclosporine A and Tacrolimus Induce Functional Impairment and Inflammatory Reactions in Endothelial Progenitor Cells. Int J Mol Sci. 2021 Sep 8;22(18):9696.
• Qu Z et al. Systematic review on potential brain dead donor estimations and conversion rates to actually realized organ donations. Transplant Rev (Orlando). 2021 Dec;35(4):100638.
• Oedingen C, Bartling T, Schrem H, Mühlbacher AC, Krauth C. Public preferences for the allocation of donor organs for transplantation: A discrete choice experiment. Soc Sci Med. 2021 Oct;287:114360.
• Ahlenstiel-Grunow T et al. Steering Transplant Immunosuppression by Measuring Virus-Specific T Cell Levels: The Randomized, Controlled IVIST Trial. J Am Soc Nephrol. 2021 Feb;32(2):502-516.
• Immenschuh S. Antibody-mediated Rejection and the Graft Endothelium in Solid Organ Transplantation. Transplantation. 2021 Nov 1;105(11):e154-e155.
• Dipresa D et al. Hemodynamic Assessment of Hollow-Fiber Membrane Oxygenators Using Computational Fluid Dynamics in Heterogeneous Membrane Models. J Biomech Eng. 2021 May 1;143(5):051010.
• Bartling T et al. 'As a surgeon, I am obliged to every single patient': evaluation of focus group discussions with transplantation physicians on the allocation of donor organs. Curr Opin Organ Transplant. 2021 Oct 1;26(5):459-467.

• Becher PM, et al. Clinical characteristics and outcomes of patients with adult congenital heart disease listed for heart and heart-lung transplantation in the Eurotransplant region. J.Heart Lung Transplant. 2020.
• Beetz O, et al. Abdominal Surgery in Patients with Ventricular Assist Devices: a Single-Center Report . ASAIO J. 2020.
• Hanke JS, et al. First-in-man explantation of a HeartMate 3 left ventricular assist device via customized plug. Eur.J.Cardiothorac.Surg. 2020.
• Ius F, et al. Heart Preservation with the Organ Care System in Extended Criteria Donors: A Single-Center Experience. Thorac.Cardiovasc.Surg. 2020.
• Ius F, et al. Heart Preservation with the Organ Care System in Extended Criteria Donor Hearts: A Three-Center Experience. J Heart Lung Transplant,.2020.
• Ius F, et al.  Treatment of Anti-HLA Donor-Specific Antibodies in Heart Transplantation: A Single-Center Experience. J Heart Lung Transplant. 2020.
• Kühne JF, et al. In Combined Heart/Lung Transplantation, the Reperfusion Response in Recipients is Dominated by Heart-Associated Cytokine and Endothelial Patterns While the Ischemic Injury in the Storage Solution is Dominated by a Lung-Associated Microenvironment. J Heart Lung Transplant. 2020.
• Mogaldea A, et al. Upper-body cannulation for midterm mechanical circulatory support: A novel bridging strategy to cardiac retransplantation. Int.J.Artif.Organs. 2020.
• Rojas SV, et al. Ex vivo Heart Perfusion for Heart Transplantation: A Single-Center Update after 5 Years. Thorac.Cardiovasc.Surg. 2020.
• Rojas SV, et al. Ex Vivo Organ Perfusion for Heart Procurement in High-Risk Transplantations: A Multicenter Study. J Heart Lung Transplant, 2020.
• Sponga S, et al. Normothermic Ex-Vivo Perfusion for Donor Heart Preservation in Transplantation of Patients Bridged with Ventricular Assist Devices. J Heart Lung Transplant. 2020.
• Walter C, et al. Infrastructural needs and expected benefits of telemonitoring in left ventricular assist device therapy: Results of a qualitative study using expert interviews and focus group discussions with patients. Int.J.Artif.Organs. 2020.
• Weigle CA, et al. An Immunological Model for Heterotopic Heart and Cardiac Muscle Cell Transplantation in Rats. J.Vis.Exp., 2020.
• Zimpfer D, et al. Long-Term Survival of Patients With Advanced Heart Failure Receiving an Left Ventricular Assist Device Intended as a Bridge to Transplantation: The Registry to Evaluate the HeartWare Left Ventricular Assist System. Circ.Heart Fail. 2020.

• Berenguer M, et al. Characteristics, trends and Outcomes of Liver Transplantation for Primary sclerosing cholangitis in female vs male patients: An analysis from the European Liver Transplant Registry. Transplantation. 2020.
• Busch M et Wedemeyer HH. Akutes Leberversagen - die Bedeutung einer schnellen Diagnostik und frühen Therapieeinleitung. Internist (Berl). 2020.
• Engel B, et al. The future of autoimmune liver diseases - Understanding pathogenesis and improving morbidity and mortality. Liver Int. 2020.
• Engelmann C, et al. Prevention and Management of CMV Infections after Liver Transplantation: Current Practice in German Transplant Centers . J.Clin.Med. 2020.
• Germani G, et al. Influence of donor and recipient gender on liver transplantation outcomes in Europe. Liver Int. 2020.
• Höfer A, et al. Non-invasive screening for subclinical liver graft injury in adults via donor-specific anti-HLA antibodies. Sci.Rep. 2020.
• Mederacke YS, et al. T cell receptor repertoires within liver allografts are different to those in the peripheral blood. J.Hepatol. 2020.
• Memaran N, et al.Prospective assessment of subclinical cardiovascular damage and associated factors in liver transplant recipients. Transpl.Int. 2020.
• Pflugrad H, et al.Brain function and metabolism in patients with long-term tacrolimus therapy after kidney transplantation in comparison to patients after liver transplantation. PLoS One. 2020.
• Rashidi-Alavijeh J, et al. Primary sclerosing cholangitis as an independent risk factor for cytomegalovirus infection after liver transplant. Transpl.Infect.Dis. 2020.
• Rashidi-Alavijeh J, et al. Safety and efficacy of tenofovir alafenamide in liver transplant recipients: a single center experience. Transpl.Infect.Dis. 2020.
• Schnitzbauer AA, et al. mTOR Inhibition Is Most Beneficial After Liver Transplantation for Hepatocellular Carcinoma in Patients With Active Tumors. Ann.Surg. 2020.
• Waldron LS, et al. Diaphragmatic Hernia following Pediatric Liver Transplantation: An Underappreciated Complication Prone to Recur Eur J Pediatr Surg. 2020.
• Willuweit K, et al. HLA class II donor specific antibodies are associated with graft cirrhosis after liver transplant independent of the mean fluorescence intensity level. BMC Gastroenterol. 2020. 

• Arens J, et al. Toward a Long-Term Artificial Lung. ASAIO J.. 2020.
• Bellmàs Sanz R, et al. Donor T and NK Cells with a Special Tissue-Resident Memory Phenotype Migrate into the Periphery of Lung Transplant Recipients - A Potential Feature for Tolerance Development. J Heart Lung Transplant. 2020.
• Derlin K, et al.Application of MR diffusion imaging for non-invasive assessment of acute kidney injury after lung transplantation. Medicine (Baltimore). 2020.
• Greer M et Welte T. Chronic Obstructive Pulmonary Disease and Lung Transplantation. Semin.Respir.Crit.Care.Med. 2020.
• Hacker KS, et al.Delayed non-myeloablative irradiation to induce long-term allograft acceptance in a large animal lung transplantation model. Transpl.Immunol. 2020.
• Hitz A, et al. Lung Transplant Recipients Developing Early DSA within the First Month are Characterized by a Higher Frequency of Naïve and a Lower Frequency of Memory B Cells. J Heart Lung Transplant. 2020.
• Ius F, et al. Long-term outcomes after intraoperative extracorporeal membrane oxygenation during lung transplantation. J.Heart Lung Transplant. 2020.
• Ius F, et al. Impact of Unilateral Diaphragmatic Dysfunction on Postoperative Outcome after Bilateral Lung Transplantation. Thorac.Cardiovasc.Surg. 2020.
• Ius F, et al. Six-year experience with treatment of early donor-specific anti-HLA antibodies in pediatric lung transplantation using a human immunoglobulin-based protocol. Pediatr.Pulmonol. 2020.
• Ius F, et al. Increased Frequency of Regulatory CD127low T Cells Early after Lung Transplant is Associated with Improved Graft Survival: 10-Year Single-Center Experience. J Heart Lung Transplant. 2020.
• Ius F, et al. Increased frequency of CD4(+) CD25(high) CD127(low) T cells early after lung transplant is associated with improved graft survival - a retrospective study. Transpl.Int. 2020.
• Ius F, et al. Membrane Oxygenation during Lung Transplantation and Long-Term Graft Function: Results from a 9-Year Single-Center Experience. J Heart Lung Transplant. 2020.
• Ius F, et al. Six-Year Clinical Results of an IgA-and IgM-Enriched Human Immunoglobulin-Based Therapy for Early Anti-HLA Donor Specific Antibodies after Lung Transplantation. Thorac.Cardiovasc.Surg. 2020.
• Ius F, et al. Six-Year Results of an IgA- and IgM-Enriched Immunoglobulin-Based Therapy for Early Detectable Anti-HLA Donor Specific Antibodies in Lung Transplantation. J Heart Lung Transplant. 2020.
• Janciauskiene S, et al. Plasma Acute Phase Proteins as Predictors of Chronic Lung Allograft Dysfunction in Lung Transplant Recipients. J.Inflamm.Res. 2020.
• Möhre M, et al. Factor Analyses and Validity of the Transplant Evaluation Rating Scale (TERS) in a Large Sample of Lung Transplant Candidates. Front.Psychiatry. 2020.
• Salman J, et al. Intraoperative Extracorporeal Circulatory Support in Lung Transplantation for Pulmonary Fibrosis. Ann.Thorac.Surg. 2020.
• Siemeni T, et al. Correlation of CLAD in Lung Transplant Recipients with Transplant Arteriosclerosis in Humanized Mice: A 5-years Follow Up Analysis. J Heart Lung Transplant. 2020.
• Werlein C, et al. Lung Transplant Pathology: An Overview on Current Entities and Procedures. Surg.Pathol.Clin. 2020.

• Ahlenstiel-Grunow T, et al. BK Polyomavirus-specific T Cells as a Diagnostic and Prognostic Marker for BK Polyomavirus Infections After Pediatric Kidney Transplantation. Transplantation 2020.
• Ahlenstiel-Grunow T, et al. Steering Transplant Immunosuppression by Measuring Virus-Specific T Cell Levels: The Randomized, Controlled IVIST Trial. J.Am.Soc.Nephrol. 2020.
• Ahlenstiel-Grunow T, et al. Virus-specific T cells in pediatric renal transplantation. Pediatr.Nephrol. 2020.
• Beetz O, et al. Surgical complications in pediatric kidney transplantation -Incidence, risk factors, and effects on graft survival: A retrospective single-center study. Pediatr.Transplant. 2020.
• Bünemann M, et al. Beliefs about immunosuppressant medication and correlates in a German kidney transplant population. J.Psychosom.Res. 2020.
• Callemeyn J, et al. Transcriptional Changes in Kidney Allografts with Histology of Antibody-Mediated Rejection without Anti-HLA Donor-Specific Antibodies. J.Am.Soc.Nephrol. 2020.
• de Boer S, et al. Knowledge About Immunosuppressant Medication and Its Correlates in a German Kidney Transplant Population - Results of a KTx360 degrees Substudy. Patient Prefer Adherence. 2020.
• Einecke G, et al. Factors associated with kidney graft survival in pure antibody-mediated rejection at the time of indication biopsy: Importance of parenchymal injury but not disease activity. Am.J.Transplant. 2020.
• Feddersen N, et al. Adherence in pediatric renal recipients and its effect on graft outcome, a single-center, retrospective study. Pediatr.Transplant. 2020.
• Francis A, et al. Survival after Kidney Transplantation during Childhood and Adolescence. Clin.J.Am.Soc.Nephrol. 2020.
• Halloran PF, et al. Discovering novel injury features in kidney transplant biopsies associated with TCMR and donor aging. Am.J.Transplant. 2020.
• Hanke AA, et al. Influence of Officially Ordered Restrictions During the First Wave of COVID-19 Pandemic on Physical Activity and Quality of Life in Patients after Kidney Transplantation in a Telemedicine Based Aftercare Program-A KTx360 degrees Sub Study. Int.J.Environ.Res.Public.Health. 2020.
• Hauser IA, et al. Effect of everolimus-based drug regimens on CMV-specific T-cell functionality after renal transplantation: 12-month ATHENA subcohort-study results. Eur.J.Immunol. 2020.
• Kanzelmeyer NK, et al. The role of protocol biopsies after pediatric kidney transplantation. Medicine (Baltimore). 2020.
• Kreimann K, et al. Ischemia Reperfusion Injury Triggers CXCL13 Release and B-Cell Recruitment After Allogenic Kidney Transplantation. Front.Immunol. 2020.
• Kühne JF, et al. Differential effects of Belatacept on virus-specific memory versus de novo allo-specific T cell responses of kidney transplant recipients and healthy donors. Transpl.Immunol. 2020.
• Madill-Thomsen K, et al. Discrepancy analysis comparing molecular and histology diagnoses in kidney transplant biopsies. Am.J.Transplant. 2020.
• Mazhari AL, et al. Die Versorgung von Patienten nach Nierentransplantation außerhalb der Regelversorgung: Herausforderungen und Chancen für die Nachsorge von Patienten im Projekt NTx360°. Nieren Hochdruck. 2020.
• Mehrabi A, et al. Consensus on definition and severity grading of lymphatic complications after kidney transplantation. Br.J.Surg. 2020.
• Melk A, et al. Sex disparities in dialysis initiation, access to waitlist, transplantation and transplant outcome in German patients with renal disease-A population based analysis. PLoS One. 2020.
• Mertens I, et al. Urinary Protein Biomarker Panel for the Diagnosis of Antibody-Mediated Rejection in Kidney Transplant Recipients Kidney. Int.Rep. 2020.
• Naik MG, et al. Determinants of Successful Use of Sirolimus in Renal Transplant Patients. Transplant.Proc. 2020.
• Nöhre M, et al. Obesity After Kidney Transplantation-Results of a KTx360 degrees Substudy. Front.Psychiatry. 2020.
• Pape L, et al. NTx360° - ein klinik- und sektorenübergreifendes koordiniertes, multimodales, telemedizinbasiertes Nachsorgemodell nach Nierentransplantation. Springer Gabler. 2020.
• Patecki M, et al. Long-term renal graft outcome after parathyroidectomy - a retrospective single centre study. BMC Nephrol. 2020.
• Pflugrad H, et al. Brain function and metabolism in patients with long-term tacrolimus therapy after kidney transplantation in comparison to patients after liver transplantation. PLoS One. 2020.
• Stocklassa T, et al.Sex Differences in Subclinical Cardiovascular Organ Damage After Renal Transplantation: A Single-Center Cohort Study J.Womens Health.(Larchmt) 2020.
• Süsal C, et al. Should kidney allografts from old donors be allocated only to old recipients? Transpl.Int. 2020.
• Tinel C, et al. Development and validation of an optimized integrative model using urinary chemokines for noninvasive diagnosis of acute allograft rejection. Am.J.Transplant. 2020.
• Yepes-Calderon M, et al. Post-transplantation plasma malondialdehyde is associated with cardiovascular mortality in renal transplant recipients: a prospective cohort study. Nephrol.Dial.Transplant. 2020.
• Yuzefovych Y, et al. Genetic Engineering of the Kidney to Permanently Silence MHC Transcripts During ex vivo Organ Perfusion Front.Immunol. 2020.

Transplantation

• Iske J, et al. Senolytics prevent mt-DNA-induced inflammation and promote the survival of aged organs following transplantation. Nat Commun. 2020.
• Becker F, et al. Optimizing Organ Donation: Expert Opinion from Austria, Germany, Spain and the U.K. Ann.Transplant. 2020.
• Dona D, et al. Pediatric transplantation in Europe during the COVID-19 pandemic: Early impact on activity and healthcare. Clin.Transplant. 2020.
• Kummer L, et al. Vascular Signaling in Allogenic Solid Organ Transplantation - The Role of Endothelial Cells- Front.Physiol. 2020.
• Laws HJ, et al. Impfen bei Immundefizienz : Anwendungshinweise zu den von der Standigen Impfkommission empfohlenen Impfungen. (III) Impfen bei hamatologischen und onkologischen Erkrankungen (antineoplastische Therapie, Stammzell transplantation), Organtransplantation und Asplenie. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2020.
• Mund E, et al. Clinically latent and autopsy-verified inflammatory disorders and malignant tumours in transplant patients. J.Clin.Pathol. 2020.
• Oedingen C, et al. Public preferences for the allocation of donor organs for transplantation: Focus group discussions. Health Expect. 2020.
• Qu Z, et al. Organ procurement and transplantation in Germany during the COVID-19 pandemic. Lancet. 2020.
• Timrott K, et al. The importance of MHC class II in allogeneic bone marrow transplantation  and chimerism-based solid organ tolerance in a rat model.LoS One. 2020.

Review Artikel

• Bartling T, et al. A systematic review of physicians' and patients' preferences regarding the allocation of deceased donor organs: to what extent are physicians acting as advocates for their patients? Transplantation. 2020.
• Calabrese F, et al. Organ Care System Lung resulted in lower apoptosis and iNOS expression in donor lungs. Am.J.Transplant. 2020.
• Oedingen C, et al. Systematic review and focus group discussions of public preferences for the allocation deceased donor organs as preliminary works: building a dicrete choice experiment evaluating principles of distributive justice. Transplantation. 2020.

• Barten M, et al. Comparing everolimus-based immunosuppression with reduction or withdrawal of calcineurin inhibitor reduction from six months after heart transplantation: the randomized MANDELA study. Am.J.Transplant., 2019.
• Beetz O, et al. Recipient natural killer cells alter the course of rejection of allogeneic heart grafts in rats. PLoS One. 2019.
• Figueiredo C, et al.Low immunogenic endothelial cells endothelialize the Left Ventricular Assist Device. Sci.Rep. 2019.
• Hohmann S, et al. Initial experience with telemonitoring in left ventricular assist device patients. J.Thorac.Dis. 2019.
• Ius F, et al. Cardiac Transplantation across Preformed HLA-Antibody Barriers: Results of a Peritransplant Desensitization Protocol. J Heart Lung Transplant. 2019.
• Latus H, et al. Reduced Biventricular Volumes and Myocardial Dysfunction Long-term After Pediatric Heart Transplantation Assessed by CMR. Transplantation. 2019.
• Mariani S, et al. Is this the right MOMENTUM?-evidence from a HeartMate 3 randomized trial. J.Thorac.Dis. 2019.
• Przybylek B, et al. Novel Cytokine Score and Cardiac Allograft Vasculopathy. Am J Cardiol. 2019.
• Uribarri A, et al. Prognostic Value of the Nutritional Risk Index in Candidates for Continuous Flow Left Ventricular Assist Device Therapy. Rev.Esp.Cardiol.(Engl.Ed) 2019.
• Uriel N, et al. Echocardiographic Changes in Patients Implanted with a Fully Magnetically Levitated Left Ventricular Assist Device (HeartMate 3). J.Card.Fail. 2019.

• Adam R, et al. Improved Survival in Liver Transplant Patients Receiving Prolonged-release Tacrolimus-based Immunosuppression in the European Liver Transplant Registry (ELTR): An Extension Study. Transplantation. 2019.
• Dirks M, et al. Impact of immunosuppressive therapy on brain derived cytokines after liver transplantation. Transpl Immunol. 2019.
• Fischler B, et al. Similarities and Differences in Allocation Policies for Pediatric Liver Transplantation Across the World J.Pediatr.Gastroenterol.Nutr. 2019.
• Goede LL, et al. Quantitative magnetic resonance imaging indicates brain tissue alterations in patients after liver transplantation. PLoS One. 2019.
• Harms MH, et al. Trends in liver transplantation for primary biliary cholangitis in Europe over the past three decades. Aliment Pharmacol Ther. 2019.
• Harries L, et al. Potential savings in the treatment pathway of liver transplantation: an inter-sectorial analysis of cost-rising factors. Eur J Health Econ. 2019.
• Höfer A, et al. DSA are associated with more graft injury, more fibrosis and upregulation of rejection associated transcripts in subclinical rejection. Transplantation. 2019.
• Hopp AE, et al. Hepatic Encephalopathy Is Reversible in the Long Term After Liver Transplantation. Liver Transpl. 2019.
• Kornerup L, et al. Cognitive impairment after liver transplantation: residual hepatic encephalopathy or posttransplant encephalopathy? Hepat Med. 2019.
• Mayer K, et al. Psychosocial outcome and resilience after paediatric liver transplantation in young adults. Clin.Res.Hepatol.Gastroenterol. 2019.
• Memaran N, et al. High Burden of Subclinical Cardiovascular Target Organ Damage After Pediatric Liver Transplantation. Liver Transpl. 2019.
• Möhring T, et al. Immune Status in Children Before Liver Transplantation-A Cross-Sectional Analysis Within the ChilsSFree Multicentre Cohort Study. Front Immunol. 2019.
• Pflugrad H, et al. Cerebral metabolite alterations in patients with posttransplant encephalopathy after liver transplantation. PLoS One. 2019.
• Sandmann L, et al. Treatment strategies for patients with decompensated liver cirrhosis due to hepatitis C virus infection eligible for liver transplantation: real-life data from five German transplant centers. Eur J Gastroenterol Hepatol. 2019.
• Schmitz B, et al. Brain metabolic alterations in patients with long-term calcineurin inhibitor therapy after liver transplantation. Aliment Pharmacol Ther. 2019.
• Trunečka P, et al. The Effect of Donor Age and Recipient Characteristics on Renal Outcomes in Patients Receiving Prolonged-Release Tacrolimus After Liver Transplantation: Post-Hoc Analyses of the DIAMOND Study. Ann Transplant. 2019.

• Beetz O, et al. A Case of Recurrent Pneumoperitoneum and Pneumatosis Intestinalis After Bilateral Lung Transplant. Exp Clin Transplant. 2019.
• Bertram A, et al. Adherence is associated with a favorable outcome after lung transplantation. PLoS One. 2019.
• Figueiredo C, et al. Immunoengineering of the Vascular Endothelium to Silence MHC Expression During Normothermic Ex Vivo Lung Perfusion. Hum Gene Ther. 2019.
• Glanville A, et al. Chronic lung allograft dysfunction: Definition and update of restrictive allograft syndrome-A consensus report from the Pulmonary Council of the ISHLT. J.Heart Lung Transplant. 2019.
• Gottlieb J, et al. A randomized trial of everolimus-based quadruple therapy vs standard triple therapy early after lung transplantation. Am.J.Transplant. 2019.
• Gräger N, et al. Risk Factors for Developing Nonmelanoma Skin Cancer after Lung Transplantation. J.Skin Cancer. 2019
• Ius F, et al. Five-Year Results of an IgA and IgM-Enriched Human Immunoglobulin G-Based Therapy for Early Anti-HLA Donor Specific Antibodies in 158 Lung-Transplanted Patients. J Heart Lung Transplant. 2019.
• Ius F, et al. Increased Frequency Of regulatory CD127low T Cells and of IL2+ T Cells Early after Lung Transplant is Associated with Improved Graft Survival. J Heart Lung Transplant. 2019.
• Ius F, et al. Five-Year Experience with Treatment of Early Donor Specific Anti-HLA Antibodies in Pediatric Lung Transplant Recipients. J Heart Lung Transplant. 2019.
• Kordes A, et al. Genetically diverse Pseudomonas aeruginosa populations display similar transcriptomic profiles in a cystic fibrosis explanted lung. Nat Commun. 2019.
• Law N, et al. Lack of association of Aspergillus colonization with the development of bronchiolitis obliterans syndrome in lung transplant recipients: An international cohort study. J.Heart Lung Transplant. 2019.
• Loor G, et al. Portable normothermic ex-vivo lung perfusion, ventilation, and functional assessment with the Organ Care System on donor lung use for transplantation from extended-criteria donors (EXPAND): a single-arm, pivotal trial. Lancet Respir Med. 2019.
• Moher Alsady T, et al. MRI-derived regional flow-volume loop parameters detect early-stage chronic lung allograft dysfunction. J.Magn.Reson.Imaging. 2019.
• Nöhre M, et al. Psychometric Properties of the German Version of the Pulmonary-Specific Quality-of-Life Scale in Lung Transplant Patients. Front.Psychiatry. 2019.
• Renne J, et al. Functional Pulmonary Magnetic Resonance Imaging for Detection of Ischemic Injury in a Porcine Ex-Vivo Lung Perfusion System Prior to Transplantation. Acad Radiol. 2019.
• Salman J, et al. Long-Term Results of Bilateral Lung Transplantation in Patients With End-Stage Pulmonary Lymphangioleiomyomatosis. Prog Transplant. 2019.
• Seeliger B, et al. Risk factors and outcomes of vocal cord paralysis after lung transplantation - a retrospective cohort study. Transpl Int. 2019.
• Siemeni T, et al. Transplant arteriosclerosis in humanized mice reflects chronic lung allograft dysfunction and is controlled by regulatory T cells. J Thorac Cardiovasc Surg. 2019.
• Sommer W, et al. Extended criteria donor lungs do not impact recipient outcomes in pediatric transplantation. J Heart Lung Transplant. 2019.
• Sommer W, et al. Prediction of transplant outcome after 24-hour ex vivo lung perfusion using the Organ Care System in a porcine lung transplantation model. Am J Transplant. 2019.
• Sommer W, et al. Transplantation of donor lungs with pulmonary embolism - a retrospective study. Transpl Int. 2019.
• Verleden G, et al. Chronic lung allograft dysfunction: Definition, diagnostic criteria, and approaches to treatment-A consensus report from the Pulmonary Council of the ISHLT. J.Heart Lung Transplant. 2019.
• Welte T, et al. Invasive mould infections in solid organ transplant patients: modifiers and indicators of disease and treatment response. Infection. 2019.
• Welte T, et al. Ten tips for the intensive care management of transplanted lung patients. Intensive Care Med. 2019.
• Wohlschlaeger J, et al. Lungentransplantation : Histomorphologische Diagnostik und klinische Aspekte. Pathologe. 2019.

• Abeling T, et al. Risk factors for death in kidney transplant patients: analysis from a large protocol biopsy registry. Nephrol Dial Transplant. 2019.
• Balzer MS, et al. Pre-transplant dialysis modality and long-term patient and kidney allograft outcome: A 15-year retrospective single center cohort study. Transpl Int. 2019.
• Borsum N, et al. Cytokine Profiles in Children After Pediatric Kidney Transplantation With Acute Cellular Compared to Chronic Antibody-mediated Rejection and Stable Patients: A Pilot Study. Transplant.Direct. 2019.
• Brakemeyer S, et al. Everolimus in de novo kidney transplant recipients participating in the Eurotransplant senior program: Results of a prospective randomized multicenter study (SENATOR).PLoS One. 2019.
• Chatzikyrkou C, et al. Predictors of Outcomes of Living Kidney Donation: Impact of Sex, Age and Preexistent Hypertension. Transplant Proc. 2019.
• Egelkamp J, et al. Back signaling of HLA class I molecules and T/NK cell receptor ligands in epithelial cells reflects the rejection-specific microenvironment in renal allograft biopsies. Am J Transplant. 2019.
• Haffner G, et al. CKD-MBD post kidney transplantation. Pediatr.Nephrol. 2019.
• Hanff E, et al. Development and validation of GC-MS methods for the comprehensive analysis of amino acids in plasma and urine and applications to the HELLP syndrome and pediatric kidney transplantation: evidence of altered methylation, transamidination, and arginase activity. Amino Acids. 2019.
• Hruba P, et al. Molecular Patterns Discriminate Accommodation and Subclinical Antibody-mediated Rejection in Kidney Transplantation. Transplantation. 2019.
• Kettler B, et al. Kidney graft survival of >25 years: A single center report including associated graft biopsy results. Transpl Int. 2019.
• Klewitz F, et al. Information Needs of Patients About Immunosuppressive Medication in a German Kidney Transplant Sample: Prevalence and Correlates. Front.Psychiatry. 2019.
• Lieb M, et al. Subjektiver Gesundheitszustand von Lebendnierenspendern und psychosoziale Korrelate. Nieren Hochdruck. 2019.
• Madill-Thompson K, et al. Discrepancy analysis comparing molecular and histology diagnoses in kidney transplant biopsies. Am.J.Transplant. 2019.
• Marx D, et al. Proteomics in Kidney Allograft Transplantation-Application of Molecular Pathway Analysis for Kidney Allograft Disease Phenotypic Biomarker Selection. Proteomics Clin.Appl. 2019.
• Mederacke YS, et al. Transient increase of activated regulatory T cells early after kidney transplantation. Sci Rep. 2019.
• Nöhre M, et al. Prevalence and Correlates of Cognitive Impairment in Kidney Transplant Patients Using the DemTect-Results of a KTx360 Substudy. Front.Psychiatry. 2019.
• Scheel J, et al. Psychological processing of a kidney transplantation, perceived quality of life, and immunosuppressant medication adherence. Patient Prefer Adherence. 2019 .
• Scheffner I, et al. Patient survival after kidney transplantation: important role of graft-sustaining factors as determined by predictive modeling using random survival forest analysis. Transplantation. 2019.
• Schiffer L, et al. Challenges in Long-Term Follow-Up Care of Patients After Kidney Transplantation in Specialized Transplant Centers. Gesundheitswesen. 2019.
• Schiffer L, et al. Chemokine CXCL13 as a New Systemic Biomarker for B-Cell Involvement in Acute T Cell-Mediated Kidney Allograft Rejection. Int J Mol Sci. 2019.
• Schwager Y, et al. Prediction of Three-Year Mortality After Deceased Donor Kidney Transplantation in Adults with Pre-Transplant Donor and Recipient Variables. Ann Transplant. 2019.
• Tkachenko D, et al. Dyadic Coping of Kidney Transplant Recipients and Their Partners: Sex and Role Differences. Front.Psychol. 2019.
• Van Alem C, et al. Liposomal delivery improves the efficacy of prednisolone to attenuate renal inflammation in a mouse model of acute renal allograft rejection. Transplantation. 2019.
• Van Loon, et al. Development and validation of a peripheral blood mRNA assay for the assessment of antibody-mediated kidney allograft rejection: A multicentre, prospective study. EBioMedicine. 2019.
• Wiesener A, et al. Molecular Diagnosis of Kidney Transplant Failure by the Urine. Am.J.Transplant. 2019.
• Ziemann M, et al. Preformed Donor-Specific HLA Antibodies in Living and Deceased Donor Transplantation: A Multicenter Study. Clin.J.Am.Soc.Nephrol. 2019.

Allgemein

• Figueiredo C, et al. Silencing of HLA class I on primary human hepatocytes as a novel strategy for reduction in alloreactivity. J Cell Mol Med. 2019.
• Melk A, et al. Equally Interchangeable? How Sex and Gender Affect Transplantation. Transplantation. 2019.
• Jaeckel E, et al. Tipping the Balance. Transplantation. 2019.
• Kamar N, et al. Hepatitis E Virus Ribavirin Study Group. Ribavirin for Hepatitis E Virus Infection After Organ Transplantation: A Large European Retrospective Multicenter Study. Clin.Infect.Dis.. 2019.
• Ius F, et al. Cardiac valve operations after solid organ transplantation: A single-center experience. J.Thorac.Cardiovasc.Surg. 2019.
• Blöte R, et al. Greater Susceptibility for Metabolic Syndrome in Pediatric Solid Organ and Stem Cell Transplant Recipients. Transplantation. 2019.
• Webb N, et al. Pharmacokinetics of tacrolimus granules in pediatric de novo liver, kidney, and heart transplantation: The OPTION study. Pediatr.Transplant. 2019.
• Janssens E. Widerspruchslösung bei der Organspende? Eine Umfrage bei Mitgliedern der Deutschen Gesellschaft für internistische Intensivmedizin und Notfallmedizin. Med.Klin.Intensivmed.Notfmed. 2019.

Reviews

• Oedingen C, et al. Systematic Review of Public Preferences for the Allocation of Donor Organs for Transplantation: Principles of Distributive Justice. Review article. Patient. 2019.
• Mariani S, et al. Device profile of the heartware HVAD system as a bridge-to-transplantation in patients with advanced heart failure: overview of its safety and efficacy. Expert Rev.Med.Devices. 2019.
• Rojas SV, et al. Heart failure: ventricular assist devices and cardiac transplantation : A review of current surgical innovations. Review article Chirurg. 2019.
• Scurt FG, et al. Clinical outcomes after ABO-incompatible renal transplantation: a systematic review and meta-analysis. Lancet. 2019.
• Welte T, et al. Invasive mould infections in solid organ transplant patients: modifiers and indicators of disease and treatment response. Review article. Infection. 2019.

• Chatterjee A, et al. Clinical overview of the HVAD: a centrifugal continuous-flow ventricular assist device with magnetic and hydrodynamic bearings including lateral implantation strategies. J.Thorac.Dis. 2018.
• Chatterjee A, et al. The momentum of HeartMate 3: a novel active magnetically levitated centrifugal left ventricular assist device (LVAD). J.Thorac.Dis. 2018.
• Deniz E, et al. How to do it: tips and tricks of minimal-invasive HVAD((R)) implantation-the lateral approach. J.Thorac.Dis. 2018.
• Feldmann C, et al. An acoustic method for systematic ventricular assist device thrombus evaluation with a novel artificial thrombus model. J.Thorac.Dis. 2018.
• Gärtner T, et al. In vitro study for the evaluation of transluminal aspiration as a novel treatment option for thrombosis in the HeartWare HVAD. Int.J.Artif.Organs. 2018.
• Hanke JS, et al. Driving After Left Ventricular Assist Device Implantation. Artif.Organs. 2018.
• Hanke JS, et al. Five-year results of patients supported by HeartMate II: outcomes and adverse events. Eur.J.Cardiothorac.Surg. 2018.
• Hanke JS, et al. Left ventricular assist device exchange for the treatment of HeartMate II pump thrombosis. J.Thorac.Dis. 2018.
• Ricklefs M, et al. A new tool for an explantation strategy of HeartMate 3 left ventricular assist device. J.Thorac.Dis. 2018.
• Ricklefs M, et al. Less Invasive Surgical Approaches for Left Ventricular Assist Device Implantation. Semin.Thorac.Cardiovasc.Surg. 2018.
• Ricklefs M, et al. Successful HeartMate 3 implantation in isolated right heart failure-first in man experience of right heart configuration. J.Thorac.Dis. 2018.
• Rojas SV, et al. Left Ventricular Assist Device Therapy for Destination Therapy: Is Less Invasive Surgery a Safe Alternative? Rev.Esp.Cardiol.(Engl.Ed). 2018.
• Smits JM, et al. Heart re-transplantation in Eurotransplant. Transpl Int. 2018.
• Wert L, et al. Argatroban administration as therapy for thrombosis in patients with continuous-flow ventricular assist devices. J.Thorac.Dis. 2018.
• Wert L, et al. Minimally invasive surgery improves outcome of left ventricular assist device surgery in cardiogenic shock. J.Thorac.Dis. 2018.
• Wert L, et al. Reduction of driveline infections through doubled driveline tunneling of left ventricular assist devices-5-year follow-up. J.Thorac.Dis. 2018.
• Wert L, et al. Treatment of an Intercostal Left Ventricular Assist Device Prolapse by Upgrading From HeartMate II to HeartMate 3. Artif.Organs. 2018.

• Adam R, et al. 2018 Annual Report of the European Liver Transplant Registry (ELTR) - 50-year evolution of liver transplantation. Transpl Int. 2018.
• Baumann U, et al. Survival of children after liver transplantation for hepatocellular carcinoma. Liver Transpl. 2018.
• Berenguer M, et al. The road map toward an hepatitis C virus-free transplant population. Am J Transplant. 2018.
• Cammann S, et al. Early Tracheostomy Reduces Time of Mechanical Ventilation in Respiratory High-Risk Patients After Liver Transplant. Exp Clin Transplant. 2018.
• Filali Bouami S, et al. Prognostic factors for long-term survival after adult liver transplantation. Langenbecks Arch Surg. 2018.
• Getzin T, et al. Gd-EOB-DTPA-enhanced MRI for quantitative assessment of liver organ damage after partial hepatic ischaemia reperfusion injury: correlation with histology and serum biomarkers of liver cell injury. Eur Radiol. 2018.
• Goldschmidt I, et al. Immune monitoring after pediatric liver transplantation - the prospective ChilSFree cohort study. BMC Gastroenterol. 2018.
• Heits N, et al. Evolutionary Distance Predicts Recurrence After Liver Transplantation in Multifocal Hepatocellular Carcinoma. Transplantation. 2018.
• Herzer K, et al. Impact of direct-acting antiviral therapy on the need for liver transplantation related to hepatitis C in Germany. J Hepatol. 2018.
• Hueper K, et al. Assessment of liver ischemia reperfusion injury in mice using hepatic T2 mapping: Comparison with histopathology. J Magn Reson Imaging. 2018.
• Leiskau C, et al. Side effects and efficacy of renal sparing immunosuppression in pediatric liver transplantation-A single center matched cohort study. Pediatr Transplant. 2018.
• Lipinski M, et al. Clinical characteristics of patients with liver cirrhosis and spontaneous portosystemic shunts detected by ultrasound in a tertiary care and transplantation centre. Scand J Gastroenterol. 2018.
• Madadi-Sanjani O, et al. Long-term outcome and necessity of liver transplantation in infants with biliary atresia are independent of cytokine milieu in native liver and serum. Cytokine. 2018
• Pfister ED, et al. Predictive Factors for Survival in Children Receiving Liver Transplants for Wilson's Disease: A Cohort Study Using European Liver Transplant Registry Data. Liver Transpl. 2018.
• Pflugrad H, et al. Longterm calcineurin inhibitor therapy and brain function in patients after liver transplantation. Liver Transpl. 2018.
• Qu Z, et al. Evaluation of published assessment tools for comorbidity in liver transplantation: a systematic review protocol. BMJ Open. 2018.
• Qu Z, et al.  Hangzhou criteria are more accurate than Milan criteria in predicting long-term survival after liver transplantation for HCC in Germany. Langenbecks Arch Surg. 2018.
• Schrem H, et al. Statistical approach to quality assessment in liver transplantation. Langenbecks Arch Surg. 2018.
• Sommerer C, et al. Five-year outcomes in kidney transplant patients randomized to everolimus with cyclosporine withdrawal or low-exposure cyclosporine versus standard therapy. Am J Transplant. 2018.
• Thude H, et al. The killer cell lectin-like receptor B1 (KLRB1) 503T>C polymorphism (rs1135816) and acute rejection after liver transplantation. HLA. 2018.

• Bobylev D, et al. Single lung transplantation from a donor 8 months after double lung transplantation. Am J Transplant. 2018.
• Dettmer S, et al. Lobe-wise assessment of lung volume and density distribution in lung transplant patients and value for early detection of bronchiolitis obliterans syndrome. Eur J Radiol. 2018.
• Drick N, et al. DNA-based testing in lung transplant recipients with suspected non-viral lower respiratory tract infection: A prospective observational study. Transpl Infect Dis. 2018.
• Drick N, et al. Self-reported non-adherence to immunosuppressive medication in adult lung transplant recipients-A single-center cross-sectional study. Clinical trial Clin Transplant. 2018.
• Ius F, et al. Extracorporeal membrane oxygenation as a bridge to lung transplantation may not impact overall mortality risk after transplantation: results from a 7-year single-centre experience. Eur J Cardiothorac Surg. 2018.
• Ius F, et al. Preemptive treatment of early donor-specific antibodies with IgA- and IgM-enriched intravenous human immunoglobulins in lung transplantation. Am J Transplant. 2018.
• Morlacchi LC, et al. The burden of sinus disease in cystic fibrosis lung transplant recipients. Transpl Infect Dis. 2018.
• Rademacher J, et al. Infection transmission among lung transplant couples. Transpl Infect Dis. 2018.
• Renne J, et al. Multiparametric MRI for organ quality assessment in a porcine Ex-Vivo lung perfusion system. PLoS One. 2018.
• Salman J, et al. Role for primary immunosuppression with everolimus after pulmonary transplantation. Transpl Immunol. 2018.
• Salman J, et al. The liver-first approach for combined lung and liver transplantation. Eur J Cardiothorac Surg. 2018.
• Sommer W, et al. Technique and Outcomes of Less Invasive Lung Retransplantation. Transplantation. 2018.
• Steinmeyer J, et al. Cellular and acellular ex vivo lung perfusion preserve functional lung ultrastructure in a large animal model: a stereological study. Respir Res. 2018.
• Warnecke G, et al. Normothermic ex-vivo preservation with the portable Organ Care System Lung device for bilateral lung transplantation (INSPIRE): a randomised, open-label, non-inferiority, phase 3 study. Randomized controlled trial. Lancet Respir Med. 2018.
• Zinne N, et al. Treatment of infected lungs by ex vivo perfusion with high dose antibiotics and autotransplantation: A pilot study in pigs. PLoS One. 2018.
• Zimmermann T, et al.  The Transplant Evaluation Rating Scale (TERS): A Tool for the Psychosocial Evaluation of Lung Transplant Candidates. Psychosom Med Psychother. 2018.

 

• Casper J, et al. Renal transplant recipients receiving loop diuretic therapy have increased urinary tract infection rate and altered medullary macrophage polarization marker expression. Kidney Int. 2018.
• Einecke G, et al. Fatal Pneumococcus Sepsis after Treatment of Late Antibody-Mediated Kidney Graft Rejection. Case Rep Nephrol. 2018.
• Eisenberger U, et al. Histological findings to five years after early conversion of kidney transplant patients from cyclosporine to everolimus: an analysis from the randomized ZEUS study.Randomized controlled trial. BMC Nephrol. 2018.
• Greite R, et al. Renal ischemia-reperfusion injury causes hypertension and renal perfusion impairment in the CD1 mice which promotes progressive renal fibrosis. Am J Physiol Renal Physiol. 2018.
• Kleine-Döpke D, et al. Renal cell cancer after kidney transplantation. Langenbecks Arch Surg. 2018.
• Kölling M, et al. Hypoxia-induced long non-coding RNA Malat1 is dispensable for renal ischemia/reperfusion-injury. Sci Rep. 2018.
• Littbarski SA, et al. Timing of parathyroidectomy in kidney transplant candidates with secondary hyperparathryroidism: effect of pretransplant versus early or late post-transplant parathyroidectomy. Surgery. 2018.
• Peperhove M, et al. Assessment of acute kidney injury with T1 mapping MRI following solid organ transplantation. Eur Radiol. 2018.
• Schumann-Bischoff A, et al. Distinct morphological features of acute tubular injury in renal allografts correlate with clinical outcome. Am J Physiol Renal Physiol. 2018.
• Thorenz A, et al. Enhanced activation of interleukin-10, heme oxygenase-1, and AKT in C5aR2-deficient mice is associated with protection from ischemia reperfusion injury-induced inflammation and fibrosis. Kidney Int. 2018.
• Zorn KS, et al. Development and validation of a prognostic model for kidney function 1 year after combined pancreas and kidney transplantation using pre-transplant donor and recipient variables. Langenbecks Arch Surg. 2018.

Transplantation

• Peperhove M, et al. Assessment of acute kidney injury with T1 mapping MRI following solid organ transplantation. Eur Radiol. 2018.

Reviews

• Qu Z, et al. Decision modelling for economic evaluation of liver transplantation. Review article. World J Hepatol. 2018.
• Feldmann C, et al. Left Ventricular Assist Devices - A State of the Art Review. Adv.Exp.Med.Biol. 2018.